Tenet Healthcare Q4 2023 Adj EPS $2.68 Beats $1.60 Estimate, Sales $5.38B Beat $5.29B Estimate
Portfolio Pulse from Benzinga Newsdesk
Tenet Healthcare (NYSE:THC) reported Q4 2023 adjusted EPS of $2.68, surpassing the $1.60 estimate, with sales of $5.38B exceeding the $5.29B forecast. This represents a 7.80% increase in sales compared to the same period last year.
February 08, 2024 | 11:35 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tenet Healthcare reported a significant beat on both earnings and sales estimates for Q4 2023, with adjusted EPS of $2.68 against a $1.60 estimate and sales of $5.38B against a $5.29B estimate.
Beating both earnings and sales estimates significantly, especially by a 67.5% margin for EPS, is likely to instill investor confidence and could lead to a short-term positive impact on Tenet Healthcare's stock price. The reported year-over-year sales growth of 7.80% further underscores the company's strong performance and potential for future growth.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100